1. Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real‐world data
   Shigeo Shimose et al, 2023, Hepatology Research CrossRef
2. Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma
   Daenielle Lang et al, 2024, Advances in Oncology CrossRef
3. High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapy
   Toshimitsu Tanaka et al, 2023, Journal of Gastroenterology and Hepatology CrossRef
4. Prevalence of Malnutrition in Patients with Hepatocellular Carcinoma: A Comparative Study of GLIM Criteria, NRS2002, and PG-SGA, and Identification of Independent Risk Factors
   Shengqiang Tan et al, 2024, Nutrition and Cancer CrossRef
5. Delayed Postoperative Intracerebral Hemorrhage Associated With Oral Multikinase Inhibitor Therapy for Cancer: A Case Report
   Vishal C Patel et al, 2024, Cureus CrossRef